Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)	Total	Series A Convertible Preferred Stock	Preferred Stock	Preferred Stock Series A Convertible Preferred Stock	Common Stock	Common Stock MultiGen Diagnostics, Inc	Common Stock Shareholder of the Company	Additional Paid-In Capital	Additional Paid-In Capital MultiGen Diagnostics, Inc	Additional Paid-In Capital Shareholder of the Company	Deficit Accumulated	Public Offering And Private Placement	Public Offering And Private Placement Common Stock
Balance (in shares) at Dec. 31, 2012			95,600		15,478,177
Balance at Dec. 31, 2012	$ 2,169,028		$ 96		$ 1,547			$ 57,370,017			$ (55,202,632)
Increase (Decrease) in Stockholders' Equity
Sale of common stock, net of expenses (in shares)					2,631,332
Sale of common stock, net of expenses	18,829,644							18,829,381				$ 18,829,644	$ 263
Issuance of warrants in connection with services	198,791							198,791
Stock-based compensation	1,979,364							1,979,364
Derivative liability — Warrants reclassified to additional paid-in capital	5,417,871							5,417,871
Conversion of Series A preferred stock and issuance of common stock (in shares)		(35,000)		(35,000)
Conversion of preferred stock and issuance of common stock				$ 36
Number of shares issued upon conversion of preferred stock into common stock		36,458			36,458		36,458
Conversion of Series A preferred stock and issuance of common stock					$ 4					$ 32
Issuance of common stock upon net exercise of warrant (in shares)					7,284	7,284
Issuance of common stock upon net exercise of warrant						$ 1			$ (1)
Issuance of common stock upon exercise of warrant (in shares)					715,743
Issuance of common stock upon exercise of warrants	3,599,831				$ 72			3,599,759
Issuance of common stock upon net exercise of stock option (in shares)					22,955
Issuance of common stock upon net exercise of stock options					$ 2			(2)
Issuance of common stock upon exercise of stock options (in shares)					10,833
Issuance of common stock upon exercise of stock options	38,249				$ 1			38,248
Preferred stock dividend	(29,840)										(29,840)
Net loss	(11,810,938)										(11,810,938)
Balance (in shares) at Dec. 31, 2013			60,600		18,902,782
Balance at Dec. 31, 2013	20,392,000		$ 60		$ 1,890			87,433,460			(67,043,410)
Increase (Decrease) in Stockholders' Equity
Issuance of warrant in connection with debt agreement	235,857							235,857
Stock-based compensation	2,070,195							2,070,195
Issuance of common stock upon net exercise of warrant (in shares)					13,011
Issuance of common stock upon net exercise of warrant					$ 1			(1)
Preferred stock dividend	(23,015)										(23,015)
Net loss	(14,325,484)										(14,325,484)
Balance (in shares) at Dec. 31, 2014			60,600		18,915,793
Balance at Dec. 31, 2014	8,349,553		$ 60		$ 1,891			89,739,511			(81,391,909)
Increase (Decrease) in Stockholders' Equity
Sale of common stock, net of expenses (in shares)					9,996,531
Sale of common stock, net of expenses	61,215,399				$ 1,000			61,214,399
Stock-based compensation	3,946,027							3,946,027
Derivative liability — Warrants reclassified to additional paid-in capital	435,365							435,365
Issuance of common stock upon net exercise of warrant (in shares)					277,136
Issuance of common stock upon net exercise of warrant					$ 28			(28)
Issuance of common stock upon exercise of warrant (in shares)					282,975
Issuance of common stock upon exercise of warrants	1,389,427				$ 28			1,389,399
Issuance of common stock upon exercise of stock options (in shares)					265,166
Issuance of common stock upon exercise of stock options	860,852				$ 27			860,825
Preferred stock dividend	(24,240)										(24,240)
Net loss	(27,471,094)										(27,471,094)
Balance (in shares) at Dec. 31, 2015			60,600		29,737,601
Balance at Dec. 31, 2015	$ 48,701,289		$ 60		$ 2,974			$ 157,585,498			$ (108,887,243)